Investment Summary

Accelmed Invests In SKNV

On November 14, 2022, private equity firm Accelmed invested in life science company SKNV

Investment Highlights
  • This is Accelmed’s 2nd transaction in the Life Science sector.
  • This is Accelmed’s 12th transaction in the United States.
  • This is Accelmed’s 1st transaction in Florida.

Investment Summary
Date 2022-11-14
Target SKNV
Sector Life Science
Investor(s) Accelmed
Deal Type Growth Capital

Target

SKNV

Pompano Beach, Florida, United States
SKNV is a pioneer in customized medications and skincare solutions for dermatology practices across the United States. Combining a fully integrated, in-office dispensing solution for local doctors with a digital health ecommerce platform for monthly patient refills, SKNV places the power to determine and fully manage customized prescription care paths back in the hands of local providers. The SKNV Customized Dermatology System delivers targeted results and repeat purchases through tailored regimens in preventative, curative, and maintenance skin care. SKNV is based in Pompano Beach, Florida.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Accelmed

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2009
Size Small
Type Sector Focused
DESCRIPTION

Accelmed is a global investment firm focused on providing investments in small and mid-cap private and public companies. The Firm looks to invest between $20 and $50 million in medical device companies and technologies with revenues between $20 and $70 million. Prospective transaction types include management buyouts and growth financings. Accelmed was formed in 2009 and is based in Miami, Florida.

DEAL STATS #
Overall 16 of 18
Sector (Life Science) 2 of 2
Type (Growth Capital) 5 of 5
State (Florida) 1 of 1
Country (United States) 12 of 14
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-22 Click Therapeutics

New York, New York, United States

Click Therapeutics develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Click Therapeutics was founded in 2012 and is based in New York, New York.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-09 Minerva Surgical

Santa Clara, California, United States

Minerva Surgical is a medical technology company focused on developing next-generation technology for treating excessive menstrual bleeding. Minerva Surgical was formed in 2008 and is based in Santa Clara, California.

Buy -
Mergr

Product

Company

Legal